Differences Between Influenza A and B Viruses
Both influenza A and B viruses cause epidemic human disease with similar clinical presentations, but influenza A has broader host range, faster evolutionary rate, and pandemic potential, while influenza B is restricted to humans with more stable evolution and causes only seasonal epidemics. 1
Key Structural and Biological Differences
Viral Classification and Subtypes
- Influenza A viruses are categorized into subtypes based on two surface antigens: hemagglutinin (H) and neuraminidase (N). Since 1977, H1N1, H3N2, and occasionally H1N2 subtypes have circulated in humans 1
- Influenza B viruses are not categorized into subtypes but are separated into two distinct genetic lineages: Yamagata and Victoria 1
Host Range and Reservoir
- Influenza A: Naturally infects multiple mammalian species (humans, swine, horses) and various avian species. Aquatic birds serve as the natural reservoir, enabling cross-species transmission and reassortment 2, 3, 4
- Influenza B: Infects only humans with no significant animal reservoir, which fundamentally limits its evolutionary options and pandemic potential 3, 4, 5
Evolutionary Dynamics
- Influenza A undergoes both antigenic drift (minor changes) and antigenic shift (major changes through reassortment between human and animal strains), enabling pandemic emergence 2, 1
- Influenza B undergoes antigenic drift less rapidly than influenza A and cannot undergo antigenic shift due to lack of animal reservoirs 1, 6
- The mutation rate of influenza A is approximately 3-fold higher than influenza B (2.0 × 10⁻⁶ vs 0.6 × 10⁻⁶ mutations per site per infectious cycle) 7
Molecular Pathogenic Mechanisms
Receptor Binding
- Influenza A hemagglutinin possesses structural plasticity allowing recognition of both avian-type (α2,3-linked) and human-type (α2,6-linked) sialic acid receptors, facilitating cross-species transmission 8
- Influenza B hemagglutinin preferentially binds only human-type (α2,6-linked) receptors with a more restricted binding profile 8
Polymerase Function
- Influenza A polymerase is highly dependent on host ANP32 family proteins and can adapt to various host species 8
- Influenza B polymerase is well-adapted to human ANP32A and ANP32B but shows poor compatibility with avian ANP32 proteins, restricting host range 8
Immune Evasion
- Influenza A utilizes multiple pleiotropic virulence factors (particularly NS1 protein) to extensively modulate host immune responses and inflammatory processes 8
- Influenza B has relatively streamlined immunomodulatory machinery with more limited engagement of host cell death pathways, potentially contributing to less extensive inflammatory responses 8
Clinical Differences
Disease Severity
While both viruses cause similar clinical syndromes (fever, myalgia, headache, cough, sore throat, rhinitis), some observational data suggests differences:
- In one 2017/2018 hospital cohort, influenza A patients were younger, had higher fever (38.6°C vs 38.3°C), higher inflammatory markers (CRP 41 mg/L vs 23 mg/L), more dyspnea, and higher in-hospital mortality (8.3% vs 4.7%) 9
- Influenza B patients more commonly had underlying chronic kidney disease and presented with vomiting 9
Important caveat: Symptoms overlap extensively between types, making clinical differentiation impossible without laboratory testing 1, 10. Both types show similar pathogenic potential in humans during seasonal epidemics 2.
Pandemic Potential
Only influenza A viruses can cause pandemics due to:
- Ability to undergo antigenic shift through reassortment with animal strains
- Broad host range allowing circulation in multiple species
- Capacity for direct introduction of avian strains into human populations (e.g., H5N1, H7N9)
- Low pre-existing immunity in human populations to novel subtypes 2, 1, 3
Influenza B cannot cause pandemics because it lacks an animal reservoir and cannot undergo antigenic shift, limiting it to seasonal epidemic patterns 3, 5.
Practical Clinical Implications
Diagnosis
- Clinical symptoms alone cannot distinguish between influenza A and B 1, 10
- RT-PCR is the most sensitive and specific test, rapidly differentiating types and subtypes 10
- Both types require the same diagnostic approach and testing strategies
Treatment
- Both types respond to neuraminidase inhibitors (oseltamivir, zanamivir)
- Adamantanes (amantadine, rimantadine) only work against influenza A, though widespread resistance has made them obsolete 6
- Treatment decisions should not differ based on type alone but rather on disease severity and patient risk factors